The future of cancer immunotherapy: Microenvironment-targeting combinations Review
| Authors: | Murciano-Goroff, Y. R.; Warner, A. B.; Wolchok, J. D. |
| Review Title: | The future of cancer immunotherapy: Microenvironment-targeting combinations |
| Abstract: | Immunotherapy holds the potential to induce durable responses, but only a minority of patients currently respond. The etiologies of primary and secondary resistance to immunotherapy are multifaceted, deriving not only from tumor intrinsic factors, but also from the complex interplay between cancer and its microenvironment. In addressing frontiers in clinical immunotherapy, we describe two categories of approaches to the design of novel drugs and combination therapies: the first involves direct modification of the tumor, while the second indirectly enhances immunogenicity through alteration of the microenvironment. By systematically addressing the factors that mediate resistance, we are able to identify mechanistically-driven novel approaches to improve immunotherapy outcomes. © 2020, The Author(s). |
| Journal Title: | Cell Research |
| Volume: | 30 |
| Issue: | 6 |
| ISSN: | 1001-0602 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2020-05-28 |
| Start Page: | 507 |
| End Page: | 519 |
| Language: | English |
| DOI: | 10.1038/s41422-020-0337-2 |
| PUBMED: | 32467593 |
| PROVIDER: | scopus |
| PMCID: | PMC7264181 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 July 2020 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
905Wolchok -
76Betof Warner
Related MSK Work